173 related articles for article (PubMed ID: 6216848)
1. Immune regulation in myasthenia gravis: evidence for an increased suppressor T-cell population.
Miller AE; Hudson J; Tindall RS
Ann Neurol; 1982 Oct; 12(4):341-7. PubMed ID: 6216848
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.
Berrih S; Gaud C; Bach MA; Le Brigand H; Binet JP; Bach JF
Clin Exp Immunol; 1981 Jul; 45(1):1-8. PubMed ID: 6458432
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis.
Skolnik PR; Lisak RP; Zweiman B
Ann Neurol; 1982 Feb; 11(2):170-6. PubMed ID: 6462101
[TBL] [Abstract][Full Text] [Related]
4. [T suppressor cell function in patients with myasthenia gravis].
Hu Q
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):136-9, 188. PubMed ID: 2143975
[TBL] [Abstract][Full Text] [Related]
5. [Mononuclear cell subsets in the peripheral blood of patients with myasthenia gravis].
Bu B
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):140-2, 188-9. PubMed ID: 1975232
[TBL] [Abstract][Full Text] [Related]
6. Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor.
Lisak RP; Laramore C; Levinson AI; Zweiman B; Moskovitz AR
Ann Neurol; 1986 Jan; 19(1):87-9. PubMed ID: 2936299
[TBL] [Abstract][Full Text] [Related]
7. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients.
Luther C; Adamopoulou E; Stoeckle C; Brucklacher-Waldert V; Rosenkranz D; Stoltze L; Lauer S; Poeschel S; Melms A; Tolosa E
J Immunol; 2009 Jul; 183(2):841-8. PubMed ID: 19542375
[TBL] [Abstract][Full Text] [Related]
8. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
9. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of the type 1/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients.
Masuda M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
Eur J Pharmacol; 2010 Feb; 627(1-3):325-31. PubMed ID: 19863946
[TBL] [Abstract][Full Text] [Related]
11. Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.
Jambou F; Zhang W; Menestrier M; Klingel-Schmitt I; Michel O; Caillat-Zucman S; Aissaoui A; Landemarre L; Berrih-Aknin S; Cohen-Kaminsky S
J Clin Invest; 2003 Jul; 112(2):265-74. PubMed ID: 12865414
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor T cells.
Kuroda Y; Oda K; Neshige R; Shibasaki H
Ann Neurol; 1984 Apr; 15(4):400-2. PubMed ID: 6234854
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy of myasthenia gravis.
Szobor A; Petrányi G
Acta Med Acad Sci Hung; 1970; 27(4):397-411. PubMed ID: 5314027
[No Abstract] [Full Text] [Related]
14. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.
Abramsky O; Aharonov A; Webb C; Fuchs S
Clin Exp Immunol; 1975 Jan; 19(1):11-6. PubMed ID: 1239345
[TBL] [Abstract][Full Text] [Related]
16. Clinical disorders associated with T cell subset abnormalities.
Siegel RL
Adv Pediatr; 1984; 31():447-80. PubMed ID: 6240196
[TBL] [Abstract][Full Text] [Related]
17. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
Yi Q; Lefvert AK
J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapies in myasthenia gravis.
Sanders DB; Evoli A
Autoimmunity; 2010 Aug; 43(5-6):428-35. PubMed ID: 20166870
[TBL] [Abstract][Full Text] [Related]
19. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
[TBL] [Abstract][Full Text] [Related]
20. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
